GGrantIndex
← Leaderboards

Joanne Kurtzberg

Duke University

$5,389,157
Attributed
$6,462,809
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $784.1K · FY200523
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$4,662,809 · 5
FDA$1,800,000 · 1

By mechanism

R01$1,800,000 · 1
U01$1,779,462 · 1
UG1$1,237,711 · 1
U10$967,905 · 1
P01$418,373 · 1
N01$259,358 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsProspectiveTransplantationClinical Trials NetworkHematopoietic Stem Cell TransplantationChildhoodBloodReconstitutionNon-MalignantInfectionNational Heart, Lung, And Blood InstituteManuscriptsAcuteAdultChronic Graft Versus Host DiseaseMissionFoundationsData Coordinating CenterDoseIncidenceEnrollmentEngraftmentConditioningAcademic Medical Centers

Grant awards (30)

Blood and Marrow Transplant Clinical Trials Network$172,175
UG1 · FY2023 · HL
Blood and Marrow Transplant Clinical Trials Network$175,129
UG1 · FY2022 · HL
Blood and Marrow Transplant Clinical Trials Network$178,125
UG1 · FY2021 · HL · contact PI
Data Enabled Automation for the Improved Efficiency, Yield, and Reproducibility of the Manufacturing of Human Umbilical Cord Tissue Mesenchymal Stromal Cells for Clinical Therapeutic Use$600,000
R01 · FY2020 · FD
Blood and Marrow Transplant Clinical Trials Network$181,064
UG1 · FY2020 · HL · contact PI
Data Enabled Automation for the Improved Efficiency, Yield, and Reproducibility of the Manufacturing of Human Umbilical Cord Tissue Mesenchymal Stromal Cells for Clinical Therapeutic Use$600,000
R01 · FY2019 · FD
Blood and Marrow Transplant Clinical Trials Network$184,109
UG1 · FY2019 · HL · contact PI
Data Enabled Automation for the Improved Efficiency, Yield, and Reproducibility of the Manufacturing of Human Umbilical Cord Tissue Mesenchymal Stromal Cells for Clinical Therapeutic Use$600,000
R01 · FY2018 · FD
Blood and Marrow Transplant Clinical Trials Network$177,927
UG1 · FY2018 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$169,182
UG1 · FY2017 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$162,495
U10 · FY2016 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$162,495
U10 · FY2015 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$162,495
U10 · FY2014 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$162,495
U10 · FY2013 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$162,495
U10 · FY2012 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network$155,430
U10 · FY2011 · HL · contact PI
Competing Application for Blood and Marrow Transplant Network$160,215
U01 · FY2010 · HL · contact PI
Competing Application for Blood and Marrow Transplant Network$90,743
U01 · FY2009 · HL · contact PI
Competing Application for Blood and Marrow Transplant Network$1
U01 · FY2008 · HL · contact PI
Competing Application for Blood and Marrow Transplant Network$1
U01 · FY2007 · HL · contact PI
Competing Application for Blood and Marrow Transplant Network$164,938
U01 · FY2006 · HL · contact PI
Core Clinical Center Application for Duke University Me*$2
U01 · FY2005 · HL
Core Clinical Center Application for Duke University Me*$405,001
U01 · FY2004 · HL
Core Clinical Center Application for Duke University Me*$405,001
U01 · FY2003 · HL
Clinical studies of cord blood$418,373
P01 · FY2002 · HL
Core Clinical Center Application for Duke University Me*$150,001
U01 · FY2002 · HL
Core Clinical Center Application for Duke Univeristy Me*$403,559
U01 · FY2001 · HL
TRANSPLANT CENTER FOR UMBILICAL CORD STEM CELL$127,855
N01 · FY2001 · HB
TRANSPLANT CENTER FOR UMBILICAL CORD STEM CELL$131,503
N01 · FY2000 · HB
TRANSPLANT CENTER FOR UMBILICAL CORD STEM CELL$0
N01 · FY2000 · HB